RxDoctor Payments Data
★ My doctorsLook up a doctor →

Robert Freed

Rheumatology · Irvine, CANPI 1316026784

Payments from drug & device makers

$2,819in general payments, 2019–2025

Across 138 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$692
  • Amgen$678
  • Lilly USA, LLC$354
  • Pfizer$282
  • Bristol Myers Squibb$235
  • Sanofi$172
  • plus $406 from 9 others

What the payments were for

  • Food & beverage$2,811100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)17$692
Amgen39$678
Lilly USA, LLC20$354
Pfizer12$282
Bristol Myers Squibb21$235
Sanofi8$172
Johnson & Johnson9$121
Sobi, Inc2$51
Boehringer Ingelheim2$46
Genentech USA, Inc.2$45
E.r. Squibb & Sons, L.L.C.2$44
GSK1$30
Radius Health, Inc.1$29
Novartis1$22
Aytu Biopharma, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,819 in reported general payments places this provider in the 50th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Other rheumatology in Irvine

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →